| Extrapulmonary tuberculosis—an update on the diagnosis, treatment and drug resistance R Gopalaswamy, VNA Dusthackeer, S Kannayan, S Subbian Journal of Respiration 1 (2), 141-164, 2021 | 128 | 2021 |
| Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory A Dusthackeer, G Sekar, S Chidambaram, V Kumar, P Mehta, ... Indian Journal of Medical Research 142 (5), 568-574, 2015 | 59 | 2015 |
| Construction and evaluation of luciferase reporter phages for the detection of active and non-replicating tubercle bacilli A Dusthackeer, V Kumar, S Subbian, G Sivaramakrishnan, G Zhu, ... Journal of Microbiological Methods 73 (1), 18-25, 2008 | 51 | 2008 |
| Factors influencing tuberculosis treatment outcome in adult patients treated with thrice-weekly regimens in India G Ramachandran, HK Agibothu Kupparam, C Vedhachalam, ... Antimicrobial agents and chemotherapy 61 (5), 10.1128/aac. 02464-16, 2017 | 47 | 2017 |
| Synthesis and biological evaluation of 2, 4, 5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis UB Karale, VS Krishna, EV Krishna, AS Choudhari, M Shukla, ... European journal of medicinal chemistry 178, 315-328, 2019 | 44 | 2019 |
| Differential Culturability of Mycobacterium tuberculosis in Culture-Negative Sputum of Patients With Pulmonary Tuberculosis and in a Simulated Model of Dormancy A Dusthackeer, M Balasubramanian, G Shanmugam, S Priya, CR Nirmal, ... Frontiers in microbiology 10, 2381, 2019 | 43 | 2019 |
| Characterization of temperate phage Che12 and construction of a new tool for diagnosis of tuberculosis V Kumar, P Loganathan, G Sivaramakrishnan, J Kriakov, A Dusthakeer, ... Tuberculosis 88 (6), 616-623, 2008 | 42 | 2008 |
| Novel 1, 3, 4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis VB Makane, VS Krishna, EV Krishna, M Shukla, B Mahizhaveni, S Misra, ... Future Medicinal Chemistry 11 (6), 499-510, 2019 | 39 | 2019 |
| Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance R Peraman, SK Sure, VNA Dusthackeer, NB Chilamakuru, ... Future Journal of Pharmaceutical Sciences 7, 1-25, 2021 | 38 | 2021 |
| Anti-tubercular and probiotic properties of coagulase-negative staphylococci isolated from Koozh, a traditional fermented food of South India A Khusro, C Aarti, A Dusthackeer, P Agastian Microbial pathogenesis 114, 239-250, 2018 | 33 | 2018 |
| Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis VB Makane, VS Krishna, EV Krishna, M Shukla, B Mahizhaveni, S Misra, ... European Journal of Medicinal Chemistry 164, 665-677, 2019 | 32 | 2019 |
| Antimycobacterial potentials of quercetin and rutin against Mycobacterium tuberculosis H37Rv K Sasikumar, AR Ghosh, A Dusthackeer 3 Biotech 8, 1-6, 2018 | 29 | 2018 |
| Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5, 6, 7, 8-tetrahydropyrido [4′, 3′: 4, 5] thieno [2, 3-d] pyrimidin-4 (3H)-one schiff bases M Narender, K Umasankar, J Malathi, AR Reddy, KR Umadevi, ... Bioorganic & Medicinal Chemistry Letters 26 (3), 836-840, 2016 | 29 | 2016 |
| Formulation and evaluation of β-cyclodextrin-mediated inclusion complexes of isoniazid scaffolds: molecular docking and in vitro assessment of antitubercular properties L Tom, CR Nirmal, A Dusthackeer, B Magizhaveni, MRP Kurup New Journal of Chemistry 44 (11), 4467-4477, 2020 | 27 | 2020 |
| A mannose-conjugated multi-layered polymeric nanocarrier system for controlled and targeted release on alveolar macrophages RA Praphakar, H Shakila, VNA Dusthackeer, MA Munusamy, S Kumar, ... Polymer Chemistry 9 (5), 656-667, 2018 | 26 | 2018 |
| Mycobacteremia in tuberculosis patients with HIV infection R Ramachandran, S Swaminathan, S Somasundaram, VN Asgar, ... Indian Journal of Tuberculosis 50 (1), 29-32, 2002 | 26 | 2002 |
| Phosphorylated κ‐carrageenan‐facilitated chitosan nanovehicle for sustainable anti‐tuberculosis multi drug delivery R Amarnath Praphakar, AA Alarfaj, MA Munusamy, VNA Dusthackeer, ... ChemistrySelect 2 (24), 7100-7107, 2017 | 25 | 2017 |
| Bacillibactin class siderophores produced by the endophyte Bacillus subtilis NPROOT3 as antimycobacterial agents Y Nalli, S Singh, A Gajjar, B Mahizhaveni, VNA Dusthackeer, PB Shinde Letters in Applied Microbiology 76 (2), ovac026, 2023 | 18 | 2023 |
| A multi-targeting pre-clinical candidate against drug-resistant tuberculosis P Kaur, V Potluri, VK Ahuja, CN Naveenkumar, RV Krishnamurthy, ... Tuberculosis 129, 102104, 2021 | 18 | 2021 |
| Purification and characterization of anti-tubercular and anticancer protein from Staphylococcus hominis strain MANF2: In silico structural and functional insight of peptide A Khusro, C Aarti, B Mahizhaveni, A Dusthackeer, P Agastian, GA Esmail, ... Saudi Journal of Biological Sciences 27 (4), 1107-1116, 2020 | 18 | 2020 |
